Earnings Release • Mar 15, 2017
Earnings Release
Open in ViewerOpens in native device viewer
| Informazione Regolamentata n. 0481-8-2017 |
Data/Ora Ricezione 15 Marzo 2017 14:49:28 |
MTA - Star | ||
|---|---|---|---|---|
| Societa' | : | El.En. | ||
| Identificativo Informazione Regolamentata |
: | 86240 | ||
| Nome utilizzatore | : | ELENN01 - Romagnoli | ||
| Tipologia | : | IRAG 06; AVVI 16; IRAG 01 | ||
| Data/Ora Ricezione | : | 15 Marzo 2017 14:49:28 | ||
| Data/Ora Inizio Diffusione presunta |
: | 15 Marzo 2017 15:04:29 | ||
| Oggetto | : | The BoD of El.En. Spa releases the 2016 | ||
| Testo del comunicato |
Vedi allegato.
IRAG01 IRAG06 AVVI16
Press release
Consolidated turnover of 253 million euro and Group net profit over 40 million euro beat the 2016 guidance
Florence, March 15th 2017 – The board of directors of El.En. S.p.A., leader on the laser market and listed on the STAR segment of the Italian Stock exchange, discussed and approved today the consolidated financial report as of December 31st , 2016 together with the El.En. Spa draft financial report as of the same date, to be proposed for approval at the Shareholder's meeting.
With a Net income for the group of 40,4 million of Euro and consolidated Revenues at 252,6 million of Euro, the El.En. group achieved record results in 2016. After an excellent year like 2015, the group accomplished the hard task of improving its results, markedly at the EBIT level, reaching 27,6 million ( 10,9% on Revenues), up 28,4% on the historical high of 21,5 million of Euro registered in 2015.
The group confirmed and enhanced the positive trend of the past years thanks to the excellent level of competitiveness reached on the European and international markets and to the innovative features of the wide range of products offered, always able to display unique characteristics. As for non-operating items, the sale of the last block of Cynosure shares held by El.En. (Cynosure was acquired in 2002 and listed on NASDAQ in 2005 and then sold through several of transactions between 2007 and 2016) contributes to the result with a gain of about 23 million Euro.
Gabriele Clementi, President of El.En. S.p.A. said "We marked the best results of our history, we can't hide our deep satisfaction in presenting them to the market and to our shareholders. They are stemming from choices and investments made in the past, also in direst times, too, and they progressively consolidated in a very positive trend, also encountering deep appreciation on the financial markets. The price of the El.En. stock recently touched it maximum exceeding 28 Euro per share, acknowledging the soundness of our business and financial strategies.
The macroeconomic environment in which the Group operated was favorable, in particular for the exchange rate between the Euro and US Dollar remaining quite stable around \$ 1.1 per euro, a level that prevents the main competitors of El.En. - which typically bear their costs in dollars - to benefit from the competitive advantage that favored them until 2014 because of the weak dollar.
On Italian territory, the Group has been able to seize the opportunities that the slight recovery offered, thanks to tax incentives for investment provided for by the law of stability for 2016 and especially a gradual thawing of the credit granted also in the manufacturing sector.
We hereby recall that the Cynosure operation, which brought extraordinary financial benefits with the 2016 gain being the last of a long series, was equally successful from an operational point of view. Cynosure represents one of the most important clients of the Group, partner in several successes in the distribution of laser systems in North America, where we created new application segments for lasers in medicine.
Total demand for the Group's products remained firm and excellent growth results were achieved in both Medical and Industrial sectors - both in fact recording "double-digit" growth: in the industrial sector growth was 22.7% while in the Medical it was 12.9% year on year. In the medical sector we underline the excellent performance in all of our product lines, Deka, Quanta, Asclepion ASA and Esthelogue have all contributed to the overall success of the group. The same can be said for our companies in the industrial sector, Cutlite Penta, Lasit and the two Chinese Wenzhou Penta Penta Laser and Penta Chutian all able to grow in large measure in 2016.
For what concerns geographical sales mix, taking advantage of the slight recovery on our domestic markets, the group registered in Italy the strongest growth, around 22%: the direct distribution networks that operate on our territory, both in industrial and in the medical sector, based on product offer well-tailored on customer needs and on targeted investments to expand our market presence.
Growth in the European markets exceeded 11% on the non-European markets 15%. Foreign markets together represent more than 81% of the group's turnover, highlighting the global dimension of the Group.
Gross margin was 110,5 million Euro, up 14,8% on the previous year, with a 43,8% margin on Sales.
EBITDA marked 32,4 million of euro (equal to 12,8% on Sales), up 26,19% on the 25,7 million of euro of 2015.
EBIT was 27,6 million of euro up 28,35% on the 21,5 million of euro of 2015 and with a margin on Sales equal to 10,9%.
Pretax income as of December 31st, 2016 was 52,7 million of euro (up 128,1%) including the 23 million gain on the sale of Cynosure shares performed in the year for a total amount of 45 million of US dollars.
The group closed the year with net income for 40,4 million of euro up from the 14,4 million of the previous year (+181,2%).
The Net financial position as of December 31st, 2016 was positive for 82,8 million up roughly 53 million of euro on the closing of FY 2105, mainly due to the sale of Cynosure shares. During the second quarter of 2016 dividends were paid by El.En. S.p.A. for 5,8 million of euro and by the controlled companies Deka Mela S.r.l., Lasit S.p.A., e ASA S.r.l. for a total of 0,6 million of euro.
The Company registered Net revenue for 57,3 million of euro slightly lower than the 62,2 million of euro as of December 31st,2015.
EBIT was 4,0 million of euro (7,8 million of euro in 2015), while pre-tax income was equal to 44,0 million of euro, up on the 9,0 million of euro of 2015. The year closed with a Net income of 41,5 million of euro compared to 6,3 million of 2015.
The 2016 results were the best ever achieved by the Group in terms of turnover, operating profit and net income.
As at the beginning of last year, the aspiration to overcome the newly set records represented a challenging task, also due to a few unique events occurred in 2016: first of all the gain on the sale of Cynosure shares, but also some exceptional or extraordinary performance from an operational point of view.
We expect that that favorable market trends may again allow for 2017 a sales growth exceeding 5%. Some internal reorganization, a less favorable mix of products sold, some extraordinary costs make it difficult to achieve the 2016 EBIT, which is the maximum target for the year.
The Board of Directors also discussed, based on the information received by the involved Directors, the persistence of the independence requisites for the Directors that declared themselves independent. The Board of Directors received the documents submitted by the Board of Statutory Auditors about the result of the annual verification of the compliance with the criteria of independence for Statutory Auditors.
Moreover the Board of Directors approved the annual Governance Report and Shareholding and the Report on Remuneration including the guidelines of the remuneration policy 2017-2018.
The Board of Directors has resolved to call the annual Shareholder meeting for April 27th, 2017 (first call) and May 15th, 2017 (second call) and it resolved to propose to distribute a dividend of 0,40 euro per share, in accordance with art. 2357-ter c.c., to be paid on May 31st 2017, to be assigned on May 29th , 2017 (coupon no. 15) with record date May 30th 2017.
The manager in charge of preparing the corporate accounting records, Enrico Romagnoli, declares, pursuant to paragraph 2, article 154-bis of the Consolidated Finance Law, that the accounting disclosures provided in this document correspond to the accounting records, books and entries.
On 3rd October 2012 the board of directors resolved, by opting-out as allowed by artt. 70, paragraph 8 and 71, paragraph 1-bis of the Issuers' Regulation Consob 11971/99, to make exceptions to make available to the public the provided informative documents in the event of significant mergers, spin-offs, share capital increase by means of the conferral of assets in kind, takeover and transfers.
The annual financial Report, including the yearly financial Report draft, the consolidated financial Report, the management Report and the statement as required by art. 154-bis, comma 5, TUF, the Auditors report and the Board of Statutory Auditors Report, the Board of Directors report on the agenda of the Shareholders meeting and also the report on remuneration ex art. 123-ter TUF will be available to the public at the company's premises, on the internet site www.elengroup.com, at Borsa Italiana and in the authorized storage device within the time deadlines required by the law. Within the term provided by law and regulation further documents and information about the shareholders' meeting shall be available on the website of the company.
* * * * * *
Friday March 17, 2017 at 16.00 CET (3:00pm GMT, 10.00am EST) a conference call will be held with the financial community during which the Group's economic and financial results of 2016 will be discussed. It will be possible to connect to the call by dialing the following numbers: from Italy +39 02 8058811, from UK +44 1 212818003, from USA +1 718 7058794.
The presentation slides can be downloaded before the conference call from the Investor Relations page on EL.EN. web site: http://www.elengroup.com/en/investor-relationsen/company-presentations
* * * * * *
Attachments:
(With reference to the attached financial statements, it should be noted that the audit has not yet been completed).
El.En., an Italian company, is the parent of a high-.tech industrial group operating in the optoelectronics sector. Based on proprietary technology and multidisciplinary know-how, the El.En Group manufactures laser sources (gas, semiconductor, solid-state and liquid) and innovative laser systems for medical and industrial applications. The El.En. Group is the laser market leader in Italy and among the top operators in Europe. It designs, manufactures and sells worldwide:
- Medical laser equipment used in dermatology, cosmetics, physiotherapy, dentistry and gynecology;
- Industrial laser systems for applications ranging from cutting, marking and welding metals, wood, plastic and glass to decorating leather and textiles and restoring/conserving artwork;
- Laser systems for scientific research
EL.EN has been listed on the Star (MTA) of Borsa Italiana. Its market floatation is approximately 41% and its market capitalization amounts to Euro 530 million.
Cod. ISIN: IT0005188336 Sigla: ELN Listed on MTA Mkt cap.: 530 million of euro Cod. Reuters: ELN.MI Cod. Bloomberg: ELN IM
For further information:
El.En S.p.A. Investor Relations Enrico ROMAGNOLI - [email protected] Tel. +39 055 8826807
Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI - [email protected] Simona D'AGOSTINO - [email protected] Silvia MARONGIU - [email protected] Tel. +39 06-69923324
| Income Statement | 31/12/2016 | Inc % | 31/12/2015 | Inc % | Var. % |
|---|---|---|---|---|---|
| Revenues | 252.646 | 100,0% | 217.670 | 100,0% | 16,07% |
| Change in inventory of finished goods and WIP | 3.401 | 1,3% | 1.569 | 0,7% | 116,74% |
| Other revenues and income | 3.224 | 1,3% | 2.326 | 1,1% | 38,59% |
| Production value | 259.272 | 102,6% | 221.566 | 101,8% | 17,02% |
| Purchase of raw materials | 129.636 | 51,3% | 114.201 | 52,5% | 13,52% |
| Change in inventory of raw material | (1.587) | -0,6% | (6.177) | -2,8% | -74,31% |
| Other direct services | 20.689 | 8,2% | 17.224 | 7,9% | 20,12% |
| Gross margin | 110.533 | 43,8% | 96.318 | 44,2% | 14,76% |
| Other operating services and charges | 32.030 | 12,7% | 28.515 | 13,1% | 12,33% |
| Added value | 78.503 | 31,1% | 67.803 | 31,1% | 15,78% |
| Personnel costs | 46.116 | 18,3% | 42.136 | 19,4% | 9,44% |
| EBITDA | 32.388 | 12,8% | 25.666 | 11,8% | 26,19% |
| Depreciation, amortization and other accruals | 4.794 | 1,9% | 4.167 | 1,9% | 15,03% |
| EBIT | 27.594 | 10,9% | 21.499 | 9,9% | 28,35% |
| Net financial income (charges) | 1.933 | 0,8% | 1.346 | 0,6% | 43,65% |
| Share of profit of associated companies | 186 | 0,1% | 278 | 0,1% | -33,18% |
| Other net income (charges) | 23.009 | 9,1% | (10) | 0,0% | |
| Income (loss) before taxes | 52.721 | 20,9% | 23.113 | 10,6% | 128,10% |
| Income taxes | 9.728 | 3,9% | 7.064 | 3,2% | 37,72% |
| Income (loss) for the financial period | 42.993 | 17,0% | 16.049 | 7,4% | 167,88% |
| Minority interest | 2.586 | 1,0% | 1.678 | 0,8% | 54,06% |
| Net income (loss) | 40.408 | 16,0% | 14.371 | 6,6% | 181,18% |
| Statement of financial position | 31/12/2016 | 31/12/2015 | Variation |
|---|---|---|---|
| Intangible assets | 3.896 | 3.858 | 38 |
| Tangible assets | 39.616 | 32.621 | 6.995 |
| Equity investments | 3.818 | 44.556 | -40.739 |
| Deferred tax asset | 6.526 | 6.085 | 441 |
| Other non current assets | 10.881 | 10.646 | 235 |
| Non current assets | 64.737 | 97.766 | -33.029 |
| Inventories | 62.138 | 58.061 | 4.077 |
| Account receivables | 62.446 | 61.327 | 1.119 |
| Tax receivables | 5.213 | 7.826 | -2.613 |
| Other receivables | 8.564 | 7.262 | 1.302 |
| Financial instruments | 0 | 1.965 | -1.965 |
| Cash and cash equivalents | 97.589 | 46.990 | 50.600 |
| Current assets | 235.950 | 183.431 | 52.519 |
| Total Assets | 300.687 | 281.197 | 19.491 |
| Total shareholders' equity | 192.699 | 179.539 | 13.160 |
| Severance indemnity | 3.861 | 3.376 | 485 |
| Deferred tax liabilities | 1.607 | 1.638 | -31 |
| Provision for risks and charges | 3.514 | 2.890 | 625 |
| Financial debts and liabilities | 4.342 | 4.998 | -656 |
| Non Current Liabilities | 13.324 | 12.902 | 422 |
| Financial debts | 10.613 | 14.363 | -3.750 |
| Account payables | 44.694 | 42.065 | 2.629 |
| Income tax payables | 4.285 | 3.842 | 443 |
| Other current payables | 35.072 | 28.487 | 6.586 |
| Current liabilities | 94.664 | 88.756 | 5.908 |
| Total Liabilities and Shareholders' equity | 300.687 | 281.197 | 19.491 |
| Net financial position | 31/12/2016 | 31/12/2015 | Var. |
|---|---|---|---|
| Cash and cash equivalents | 97.589 | 48.954 | 48.635 |
| Current financial receivables | 150 | 222 | -72 |
| Financial short term liabilities | -10.613 | -14.363 | 3.750 |
| Net current financial position | 87.127 | 34.813 | 52.314 |
| Financial long term liabilities | -4.342 | -4.998 | 656 |
| Net financial position | 82.784 | 29.815 | 52.969 |
| Income Statement | 31/12/2016 | Inc % | 31/12/2015 | Inc % | Var. % |
|---|---|---|---|---|---|
| Revenues | 57.291 | 100,0% | 62.182 | 100,0% | -7,86% |
| Change in inventory of finished goods and WIP | (451) | -0,8% | 1.279 | 2,1% | |
| Other revenues and income | 1.511 | 2,6% | 688 | 1,1% | 119,47% |
| Production value | 58.351 | 101,9% | 64.149 | 103,2% | -9,04% |
| Purchase of raw materials | 27.251 | 47,6% | 35.274 | 56,7% | -22,74% |
| Change in inventory of raw material | 2.193 | 3,8% | (3.721) | -6,0% | |
| Other direct services | 4.239 | 7,4% | 4.908 | 7,9% | -13,63% |
| Gross margin | 24.669 | 43,1% | 27.688 | 44,5% | -10,90% |
| Other operating services and charges | 6.175 | 10,8% | 6.223 | 10,0% | -0,78% |
| Added value | 18.494 | 32,3% | 21.465 | 34,5% | -13,84% |
| Personnel costs | 13.121 | 22,9% | 12.216 | 19,6% | 7,41% |
| EBITDA | 5.373 | 9,4% | 9.249 | 14,9% | -41,90% |
| Depreciation, amortization and other accruals | 1.358 | 2,4% | 1.406 | 2,3% | -3,44% |
| EBIT | 4.015 | 7,0% | 7.842 | 12,6% | -48,80% |
| Net financial income (charges) | 3.899 | 6,8% | 1.868 | 3,0% | 108,73% |
| Other net income (charges) | 36.079 | 63,0% | (697) | -1,1% | |
| Income (loss) before taxes | 43.993 | 76,8% | 9.013 | 14,5% | 388,10% |
| Income taxes | 2.482 | 4,3% | 2.706 | 4,4% | -8,28% |
| Income (loss) for the financial period | 41.511 | 72,5% | 6.307 | 10,1% | 558,14% |
| Statement of financial position | 31/12/2016 | 31/12/2015 | Variation |
|---|---|---|---|
| Intangible assets | 217 | 199 | 17 |
| Tangible assets | 12.679 | 13.011 | -332 |
| Equity investments | 16.535 | 57.851 | -41.316 |
| Deferred tax asset | 2.737 | 2.361 | 375 |
| Other non current assets | 10.849 | 10.646 | 203 |
| Non current assets | 43.017 | 84.069 | -41.052 |
| Inventories | 22.178 | 25.008 | -2.830 |
| Account receivables | 33.592 | 34.939 | -1.348 |
| Tax receivables | 2.489 | 4.617 | -2.128 |
| Other receivables | 6.380 | 5.331 | 1.049 |
| Financial instruments | 0 | 1.965 | -1.965 |
| Cash and cash equivalents | 57.213 | 12.583 | 44.630 |
| Current assets | 121.852 | 84.443 | 37.409 |
| Total Assets | 164.869 | 168.512 | -3.643 |
| Total shareholders' equity | 145.817 | 146.986 | -1.169 |
| Severance indemnity | 945 | 895 | 50 |
| Deferred tax liabilities | 685 | 1.156 | -471 |
| Provision for risks and charges | 489 | 492 | -3 |
| Financial debts and liabilities | 488 | 0 | 488 |
| Non Current Liabilities | 2.607 | 2.543 | 64 |
| Financial debts | 0 | 1.510 | -1.510 |
| Account payables | 11.750 | 12.159 | -409 |
| Income tax payables | 649 | 1.320 | -672 |
| Other current payables | 4.046 | 3.994 | 51 |
| Current liabilities | 16.445 | 18.984 | -2.539 |
| Total Liabilities and Shareholders' equity | 164.869 | 168.512 | -3.643 |
| Net financial position | 31/12/2016 | 31/12/2015 | Var. |
|---|---|---|---|
| Cash and cash equivalents | 57.213 | 14.548 | 42.665 |
| Current financial receivables | 63 | 124 | -61 |
| Financial short term liabilities | 0 | -1.510 | 1.510 |
| Net current financial position | 57.277 | 13.162 | 44.115 |
| Financial long term liabilities | -488 | 0 | -488 |
| Net financial position | 56.788 | 13.162 | 43.626 |
In accordance with the recommendation CESR/05-178b on alternative performance indicators, the Group uses, in addition to the financial information required by IFRS, some information derived from the latter, although not required by IFRS (non - GAAP measures). These are presented in order to allow a better assessment of the performance and the management of the group and should not be considered as alternatives to those required by IFRS.
The Group uses the following alternative performance indicators to evaluate the financial performance:
The Group uses as alternative performance indicators to evaluate their ability to cope with financial obligations:
The alternative performance measures are used by the Issuer to monitor and evaluate the performance of the group and are not defined as accounting measures either within Italian GAAP or the IAS / IFRS. Therefore, the criteria used by the Group may not be consistent with those adopted by other operators and / or groups and therefore may not be comparable.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.